Baby Genes

The researchers also found that there was no lasting psychosocial harm among families who received a monogenic disease risk finding for their infant.

ArcherDx plans to keep its research and development efforts in its current facility and move its clinical and commercial testing operations to Baby Gene's CLIA lab.

The program aims to assist hundreds of people diagnosed with PKU to obtain simple and affordable access to mutation analysis of the PAH gene.